With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

The paper, published in 2020 in the International Journal of Antimicrobial Agents, originally claimed that treatments with hydroxychloroquine, an anti-malaria drug, reduced virus levels in COVID ...

In contrast, sales revenues from Anti-malarial drugs are forecast to decline from Ush100.9 billion ($27 million) in 2024 to ...

Novel anti-malaria antibodies have been identified, potentially contributing to the next generation of malaria prevention. Researchers at the National Institutes of Health (MD, USA) have identified a ...

As billions of dollars are committed to tackling malaria and HIV in Africa yearly, one disease is killing more people than ...

The discovery of the pGlu-CSP epitope opens up new avenues for developing next-generation malaria vaccines and treatments.

Augusta Cueva-Agila explains how the Cinchona officinalis, native to the Andean foothills, produced the world’s first anti-malarial drug ...